Cargando…

Correction: Label-Free Proteomics Reveals Decreased Expression of CD18 and AKNA in Peripheral CD4(+) T Cells from Patients with Vogt-Koyanagi-Harada Syndrome

Detalles Bibliográficos
Autores principales:	Mao, Liming, Yang, Peizeng, Hou, Shengping, Li, Fuzhen, Kijlstra, Aize
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050983/ http://dx.doi.org/10.1371/annotation/2c8e3e74-556c-4e42-a5df-0b8ce294119f

Ejemplares similares

Label-Free Proteomics Reveals Decreased Expression of CD18 and AKNA in Peripheral CD4(+) T Cells from Patients with Vogt-Koyanagi-Harada Syndrome
por: Mao, Liming, et al.
Publicado: (2011)

FGFR1OP tagSNP but Not CCR6 Polymorphisms Are Associated with Vogt-Koyanagi-Harada Syndrome in Chinese Han
por: Yi, Xianglong, et al.
Publicado: (2013)

Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome
por: Li, Ke, et al.
Publicado: (2009)

Identification of Urine Metabolic Biomarkers for Vogt-Koyanagi-Harada Disease
por: Chang, Rui, et al.
Publicado: (2021)

Copy number variations and gene polymorphisms of Complement components in ocular Behcet’s disease and Vogt-Koyanagi-Harada syndrome
por: Xu, Dengfeng, et al.
Publicado: (2015)

TNFAIP3 Gene Polymorphisms in a Chinese Han Population with Vogt–Koyanagi–Harada Syndrome
por: Li, Hong, et al.
Publicado: (2013)

Association of a TNIP1 Polymorphism with Vogt-Koyanagi-Harada Syndrome but Not with Ocular Behcet’s Disease in Han Chinese
por: Shi, Yanyun, et al.
Publicado: (2014)

Optical Coherence Tomographic Features and Prognostic Values of Macular Edema in Vogt-Koyanagi-Harada Disease
por: Qin, Peng, et al.
Publicado: (2022)

PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome
por: Meng, Qianli, et al.
Publicado: (2009)

Association of a NOS3 gene polymorphism with Behçet’s disease but not with Vogt-Koyanagi-Harada syndrome in Han Chinese
por: Zhou, Yan, et al.
Publicado: (2016)

Alterations of color vision and central visual field in patients with Vogt−Koyanagi−Harada syndrome
por: Yang, Peizeng, et al.
Publicado: (2012)

Identification of differently expressed mRNAs by peripheral blood mononuclear cells in Vogt-Koyanagi-Harada disease
por: Li, Yujing, et al.
Publicado: (2021)

Increased Complement 3a Receptor is Associated with Behcet’s disease and Vogt-Koyanagi-Harada disease
por: Wang, Chaokui, et al.
Publicado: (2017)

Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population
por: Hou, Shengping, et al.
Publicado: (2008)

A Functional Variant of PTPN22 Confers Risk for Vogt-Koyanagi-Harada Syndrome but Not for Ankylosing Spondylitis
por: Zhang, Qi, et al.
Publicado: (2014)

Interleukin-10 gene polymorphisms are associated with Behcet’s disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population
por: Hu, Jianmin, et al.
Publicado: (2015)

Hypermethylation of Interferon Regulatory Factor 8 (IRF8) Confers Risk to Vogt-Koyanagi-Harada Disease
por: Qiu, Yiguo, et al.
Publicado: (2017)

miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet’s disease
por: Hou, Shengping, et al.
Publicado: (2016)

Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease
por: Yi, Xianglong, et al.
Publicado: (2011)

TRAF5 and TRAF3IP2 Gene Polymorphisms Are Associated with Behçet's Disease and Vogt-Koyanagi-Harada Syndrome: A Case-Control Study
por: Xiang, Qin, et al.
Publicado: (2014)

Copy Number Variants and Genetic Polymorphisms in TBX21, GATA3, Rorc, Foxp3 and Susceptibility to Behcet's Disease and Vogt-Koyanagi-Harada Syndrome
por: Liao, Dan, et al.
Publicado: (2015)

Association of TNFSF4 Polymorphisms with Vogt-Koyanagi-Harada and Behcet’s Disease in Han Chinese
por: Lu, Sha, et al.
Publicado: (2016)

Metabolomic Analysis of Aqueous Humor Identifies Aberrant Amino Acid and Fatty Acid Metabolism in Vogt-Koyanagi-Harada and Behcet’s Disease
por: Xu, Jing, et al.
Publicado: (2021)

Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020)

Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020)

An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021)

Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023)

The Role of Interleukin-1 Receptor-Associated Kinases in Vogt-Koyanagi-Harada Disease
por: Sun, Min, et al.
Publicado: (2014)

Rituximab in refractory Vogt–Koyanagi–Harada disease
por: Dolz-Marco, Rosa, et al.
Publicado: (2011)

Choroidal Excavation in Vogt-Koyanagi-Harada Disease
por: Hashida, Noriyasu, et al.
Publicado: (2014)

Vogt-Koyanagi-Harada syndrome presenting with encephalopathy
por: Naeini, Alireza E., et al.
Publicado: (2014)

Vogt–Koyanagi–Harada syndrome – current perspectives
por: Baltmr, Abeir, et al.
Publicado: (2016)

Vogt-Koyanagi-Harada syndrome presenting with encephalopathy
por: Naeini, Alireza E., et al.
Publicado: (2013)

Initial misdiagnosis of Vogt-Koyanagi-Harada disease
por: Shoughy, Samir S., et al.
Publicado: (2019)

Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome
por: Hosseini, Seyedeh Maryam, et al.
Publicado: (2020)

Analyses of circRNA and mRNA Profiles in Vogt–Koyanagi–Harada Disease
por: Shu, Jia, et al.
Publicado: (2021)

Integrated Analysis of Key Pathways and Drug Targets Associated With Vogt-Koyanagi-Harada Disease
por: Chen, Zhijun, et al.
Publicado: (2020)

Vogt–Koyanagi–Harada disease: headache as an initial manifestation
por: Tavsanli, Mustafa, et al.
Publicado: (2008)

Influence of molecular genetics in Vogt-Koyanagi-Harada disease
por: Ng, Joanne YW, et al.
Publicado: (2014)

Vogt-Koyanagi-Harada Syndrome following influenza vaccination
por: Kim, Moosang
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lfq7qljq9j40r04ph0thh2jnct